Cargando…
UK Kidney Association Clinical Practice Guideline: Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibition in Adults with Kidney Disease 2023 UPDATE
Large placebo-controlled trials have demonstrated kidney and cardiovascular clinical benefits of SGLT-2 inhibitors. Data from the EMPA-KIDNEY and DELIVER trials and associated meta-analyses triggered an update to the UK Kidney Association Clinical Practice Guideline on Sodium-Glucose Co-transporter-...
Autores principales: | Roddick, Alistair J., Wonnacott, Alexa, Webb, David, Watt, Angela, Watson, Michael A., Staplin, Natalie, Riding, Alex, Lioudaki, Eirini, Kuverji, Apexa, Kossi, Mohsen El, Holmes, Patrick, Holloway, Matt, Fraser, Donald, Carvalho, Chris, Burton, James O., Bhandari, Sunil, Herrington, William G., Frankel, Andrew H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598949/ https://www.ncbi.nlm.nih.gov/pubmed/37880609 http://dx.doi.org/10.1186/s12882-023-03339-3 |
Ejemplares similares
-
Net effects of sodium-glucose co-transporter-2 inhibition in different patient groups: a meta-analysis of large placebo-controlled randomized trials
por: Staplin, Natalie, et al.
Publicado: (2021) -
Japanese Clinical Practice Guidelines for Rehabilitation in Critically Ill Patients 2023 (J-ReCIP 2023)
por: Unoki, Takeshi, et al.
Publicado: (2023) -
Parathyroidectomy in chronic kidney disease
por: da Rocha, Lillian Andrade, et al.
Publicado: (2021) -
Clinical practice guideline exercise and lifestyle in chronic kidney disease
por: Baker, Luke A., et al.
Publicado: (2022) -
2023 APHRS expert consensus statements on surgery for AF
por: Nitta, Takashi, et al.
Publicado: (2023)